Joel Ackerman
CIK: 0001220630
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Oct 15, 2026CSBR
CHAMPIONS ONCOLOGY, INC.
Exercise(M)Direct69.8K shares at avg. $1.60$112K - May 7, 2026DVA
DAVITA INC.
Sale(S)Direct51.5K shares at avg. $192.10$9.9M - Mar 15, 2026DVA
DAVITA INC.
Award(A)Direct5.7K shares- - Mar 15, 2026DVA
DAVITA INC.
Tax Payment(F)Direct5.8K shares at avg. $150.72$869K - Mar 15, 2026DVA
DAVITA INC.
Tax Payment(F)Direct33.7K shares at avg. $150.72$5.1M - Mar 15, 2026DVA
DAVITA INC.
Tax Payment(F)Direct3.4K shares at avg. $150.72$507K - Mar 10, 2026DVA
DAVITA INC.
Award(A)Direct66K shares- - Mar 10, 2026DVA
DAVITA INC.
Award(A)Direct6.6K shares- - Feb 6, 2026DVA
DAVITA INC.
Exercise(M)Direct44.1K shares at avg. $108.93$4.8M - Feb 6, 2026DVA
DAVITA INC.
Disposition(D)Direct32.2K shares at avg. $149.22$4.8M - Feb 6, 2026DVA
DAVITA INC.
Tax Payment(F)Direct5.1K shares at avg. $149.22$761K - Nov 5, 2025CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
21.2K shares at avg. $6.80- - Oct 30, 2025CSBR
CHAMPIONS ONCOLOGY, INC.
Exercise(M)Direct94.4K shares at avg. $2.10$198K - Mar 15, 2025DVA
DAVITA INC.
Award(A)Direct6K shares- - Mar 15, 2025DVA
DAVITA INC.
Tax Payment(F)Direct3.3K shares at avg. $143.45$478K - Mar 15, 2025DVA
DAVITA INC.
Tax Payment(F)Direct3.1K shares at avg. $143.45$444K - Mar 12, 2025DVA
DAVITA INC.
Award(A)Direct7.4K shares- - Mar 12, 2025DVA
DAVITA INC.
Award(A)Direct7.2K shares- - Nov 12, 2024CSBR
CHAMPIONS ONCOLOGY, INC.
Award(A)DirectOption to purchase Common Stock
43.2K shares at avg. $4.64- - Oct 31, 2024CSBR
CHAMPIONS ONCOLOGY, INC.
Exercise(M)Direct88.5K shares at avg. $2.10$186K - Oct 31, 2024CSBR
CHAMPIONS ONCOLOGY, INC.
Exercise(M)Direct16.7K shares at avg. $5.43$91K - Sep 16, 2024DVA
DAVITA INC.
Tax Payment(F)Direct21.6K shares at avg. $163.56$3.5M - Sep 16, 2024DVA
DAVITA INC.
Disposition(D)Direct36.7K shares at avg. $163.56$6.0M - Sep 16, 2024DVA
DAVITA INC.
Exercise(M)Direct79K shares at avg. $75.95$6.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | CSBR CHAMPIONS ONCOLOGY, INC. | Exercise(M) | 69,794 | $1.60 | $111,670 | Direct |
| May 7, 2026 | DVA DAVITA INC. | Sale(S) | 51,471 | $192.10 | $9,887,528 | Direct |
| Mar 15, 2026 | DVA DAVITA INC. | Award(A) | 5,706 | - | $0 | Direct |
| Mar 15, 2026 | DVA DAVITA INC. | Tax Payment(F) | 5,765 | $150.72 | $868,901 | Direct |
| Mar 15, 2026 | DVA DAVITA INC. | Tax Payment(F) | 33,693 | $150.72 | $5,078,209 | Direct |
| Mar 15, 2026 | DVA DAVITA INC. | Tax Payment(F) | 3,362 | $150.72 | $506,721 | Direct |
| Mar 10, 2026 | DVA DAVITA INC. | Award(A) | 65,997 | - | $0 | Direct |
| Mar 10, 2026 | DVA DAVITA INC. | Award(A) | 6,585 | - | $0 | Direct |
| Feb 6, 2026 | DVA DAVITA INC. | Exercise(M) | 44,065 | $108.93 | $4,800,000 | Direct |
| Feb 6, 2026 | DVA DAVITA INC. | Disposition(D) | 32,168 | $149.22 | $4,800,109 | Direct |
| Feb 6, 2026 | DVA DAVITA INC. | Tax Payment(F) | 5,100 | $149.22 | $761,022 | Direct |
| Nov 5, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 21,216 | $6.80 | - | Direct |
| Oct 30, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | Exercise(M) | 94,405 | $2.10 | $198,251 | Direct |
| Mar 15, 2025 | DVA DAVITA INC. | Award(A) | 5,995 | - | - | Direct |
| Mar 15, 2025 | DVA DAVITA INC. | Tax Payment(F) | 3,331 | $143.45 | $477,832 | Direct |
| Mar 15, 2025 | DVA DAVITA INC. | Tax Payment(F) | 3,093 | $143.45 | $443,691 | Direct |
| Mar 12, 2025 | DVA DAVITA INC. | Award(A) | 7,394 | - | - | Direct |
| Mar 12, 2025 | DVA DAVITA INC. | Award(A) | 7,221 | - | - | Direct |
| Nov 12, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | Award(A) Option to purchase Common Stock | 43,190 | $4.64 | - | Direct |
| Oct 31, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | Exercise(M) | 88,470 | $2.10 | $185,787 | Direct |
| Oct 31, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | Exercise(M) | 16,667 | $5.43 | $90,502 | Direct |
| Sep 16, 2024 | DVA DAVITA INC. | Tax Payment(F) | 21,602 | $163.56 | $3,533,223 | Direct |
| Sep 16, 2024 | DVA DAVITA INC. | Disposition(D) | 36,684 | $163.56 | $6,000,035 | Direct |
| Sep 16, 2024 | DVA DAVITA INC. | Exercise(M) | 78,999 | $75.95 | $5,999,974 | Direct |
1-24 of 24 transactions
About ACKERMAN JOEL
ACKERMAN JOEL (SEC CIK 0001220630) files insider reports with the SEC as Director of CHAMPIONS ONCOLOGY, INC. (CSBR) and CFO and Treasurer of DAVITA INC. (DVA).
Signal8 holds 12 ownership filings by ACKERMAN JOEL, all Form 4s, filed between Sep 17, 2024 and Oct 16, 2026. Those filings report 24 transactions, from Sep 16, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ACKERMAN JOEL's filings is in HACKENSACK, NJ.
Recent filings by ACKERMAN JOEL
- Oct 15, 2026: Option exercise of CSBR shares (Form 4, code M).
- May 7, 2026: Open-market sale of DVA shares (Form 4, code S).
- Mar 15, 2026: Grant or award of DVA shares (Form 4, code A).
- Mar 15, 2026: Tax withholdings of DVA shares (3 lines, Form 4, code F).
- Mar 10, 2026: Grants or awards of DVA shares (2 lines, Form 4, code A).
Other insiders filing for CHAMPIONS ONCOLOGY, INC. (CSBR)
- Brainin Robert Lawrence, Director
- Breitfeld Philip P., Director
- SIDRANSKY DAVID, Director
- Mendelson Daniel Newman, Director
- TOBIN SCOTT R, Director